The post Insufficient Sleep Is A Growing Crisis appeared on BitcoinEthereumNews.com. Melatonin is one of the most widely used sleep supplements. getty A study publishedThe post Insufficient Sleep Is A Growing Crisis appeared on BitcoinEthereumNews.com. Melatonin is one of the most widely used sleep supplements. getty A study published

Insufficient Sleep Is A Growing Crisis

Melatonin is one of the most widely used sleep supplements.

getty

A study published in 2018 in Healthcare found that in a study of nearly 20,000 individuals, it was reported that almost 27.3% individuals reported they had some type of sleep disorder. Another more recent study indicates that nearly 33% of adults reported insufficient sleep and short-sleep cycles. With growing economies, increasing labor needs and rising wage challenges, insufficient sleep has grown to become a worldwide phenomenon. In fact, many experts attribute these growing trends to increasing stress levels as a part of a viscious cycle: “It is believed that the relationship between stress and sleep is bidirectional—that is, stress can disrupt sleep and sleep loss can increase subsequent stress level.”

Research has also overwhelmingly indicated that lack of sleep can lead to numerous health detriments, including chronic disease, mental health deterioration and even behavioral disorders.

People are increasingly realizing this problem; with increasingly busy lives, more screen time and poorer sleep hygiene, individuals are increasingly relying on supplements, such as melatonin, to help them sleep more.

A new study published by the American Heart Association late last year found an association between long-term melatonin use and heart failure. Specifically, the study reviewed records of over 130,000 adults who used melatonin for needs related to insomnia or sleep disturbances and found a higher likelihood of being diagnosed with heart failure leading to hospitalization. Though not necessarily a finding of causality, the study calls for more research and awareness into the common and routine use of melatonin by millions of individuals daily.

Melatonin is a hormone that is naturally produced by the body to help regulate the sleep-wake cycle; typically, its levels increase during darkness and decrease during daylight, mirroring natural human circadian rhythms. The hormone binds to MT1 and MT2 receptors, triggering a variety of downstream physiological processes to induce fatigue, sleepiness and a generalized “tone of rest.”

For years, synthetic preparations of melatonin have been available for purchase by consumers over-the-counter and commonly marketed as a sleeping aid or solution for circiadian disturbances. However, as the substance is considered a supplement and not a medicine, formulations by manufacturers often bypass strict regulatory controls. In fact, in Europe and countries in Asia, melatonin cannot be acquired without a doctor’s prescription due to the significant impacts it can have with long-term use.

Another study published last year in the World Journal of Pediatrics found that the long-term effects of melatonin on children are simply unknown, despite skyrocketing use in pediatric populations globally. The study also cites that there is no clear efficacy or safety data which can strongly point towards downstream physiologic and pathologic impacts. Despite a lack of clear data on the safety and prognostic findings, melatonin use in young children is common, underscoring the need for more research in age-specific cohorts. Per a recent literature review, it was found that “the use of melatonin as a sleep aid for children younger than age 6 has increased around the world over the last 20 years, and especially over the last decade. In countries where melatonin requires a prescription, these prescriptions have increased by as much as 500% in some areas. Moreover, the studies showed increases in extended use of melatonin, with young children getting refills two and three years after the initial prescription.”

Fortunately, there has been more awareness and education over the past decade regarding non-medication related interventions to improve sleep for both pediatric and adult populations. Wellness clinics are increasingly emerging across the globe to help institute better sleep routines and methods for patients. New wearbles and activity trackers are including sleep monitoring into their hardware. Even new phone applications have been developed solely for the endeavor of helping users sleep. There is also more research and conversation around this topic. Experts broadly encourage improving sleep hygiene with easy but key changes including maintaining a consistent schedule, a darker environment during sleeping hours, less screen time prior to sleep, and consistent day-time habits that promote more regular circadian rhythms, including caffeine restriction and exercise. Through these methods, the hope is that societal outcomes for sleep efficacy can improve.

Source: https://www.forbes.com/sites/saibala/2026/01/21/insufficient-sleep-is-a-growing-crisis/

Market Opportunity
Humans.ai Logo
Humans.ai Price(HEART)
$0,001619
$0,001619$0,001619
-0,43%
USD
Humans.ai (HEART) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

American Bitcoin’s $5B Nasdaq Debut Puts Trump-Backed Miner in Crypto Spotlight

American Bitcoin’s $5B Nasdaq Debut Puts Trump-Backed Miner in Crypto Spotlight

The post American Bitcoin’s $5B Nasdaq Debut Puts Trump-Backed Miner in Crypto Spotlight appeared on BitcoinEthereumNews.com. Key Takeaways: American Bitcoin (ABTC) surged nearly 85% on its Nasdaq debut, briefly reaching a $5B valuation. The Trump family, alongside Hut 8 Mining, controls 98% of the newly merged crypto-mining entity. Eric Trump called Bitcoin “modern-day gold,” predicting it could reach $1 million per coin. American Bitcoin, a fast-rising crypto mining firm with strong political and institutional backing, has officially entered Wall Street. After merging with Gryphon Digital Mining, the company made its Nasdaq debut under the ticker ABTC, instantly drawing global attention to both its stock performance and its bold vision for Bitcoin’s future. Read More: Trump-Backed Crypto Firm Eyes Asia for Bold Bitcoin Expansion Nasdaq Debut: An Explosive First Day ABTC’s first day of trading proved as dramatic as expected. Shares surged almost 85% at the open, touching a peak of $14 before settling at lower levels by the close. That initial spike valued the company around $5 billion, positioning it as one of 2025’s most-watched listings. At the last session, ABTC has been trading at $7.28 per share, which is a small positive 2.97% per day. Although the price has decelerated since opening highs, analysts note that the company has been off to a strong start and early investor activity is a hard-to-find feat in a newly-launched crypto mining business. According to market watchers, the listing comes at a time of new momentum in the digital asset markets. With Bitcoin trading above $110,000 this quarter, American Bitcoin’s entry comes at a time when both institutional investors and retail traders are showing heightened interest in exposure to Bitcoin-linked equities. Ownership Structure: Trump Family and Hut 8 at the Helm Its management and ownership set up has increased the visibility of the company. The Trump family and the Canadian mining giant Hut 8 Mining jointly own 98 percent…
Share
BitcoinEthereumNews2025/09/18 01:33
China Bans Nvidia’s RTX Pro 6000D Chip Amid AI Hardware Push

China Bans Nvidia’s RTX Pro 6000D Chip Amid AI Hardware Push

TLDR China instructs major firms to cancel orders for Nvidia’s RTX Pro 6000D chip. Nvidia shares drop 1.5% after China’s ban on key AI hardware. China accelerates development of domestic AI chips, reducing U.S. tech reliance. Crypto and AI sectors may seek alternatives due to limited Nvidia access in China. China has taken a bold [...] The post China Bans Nvidia’s RTX Pro 6000D Chip Amid AI Hardware Push appeared first on CoinCentral.
Share
Coincentral2025/09/18 01:09
The Japanese House of Representatives has been formally dissolved.

The Japanese House of Representatives has been formally dissolved.

PANews reported on January 23 that, according to CCTV, the Japanese Diet opened and the House of Representatives held a plenary session. Speaker Fukushiro Nukaga
Share
PANews2026/01/23 12:08